nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—RRM2—Hydroxyurea—brain cancer	0.384	0.481	CbGbCtD
Clofarabine—RRM1—Hydroxyurea—brain cancer	0.384	0.481	CbGbCtD
Clofarabine—ABCG2—Carboplatin—brain cancer	0.0166	0.0207	CbGbCtD
Clofarabine—ABCG2—Etoposide—brain cancer	0.0139	0.0174	CbGbCtD
Clofarabine—RRM1—E2F transcription factor network—HIC1—brain cancer	0.00279	0.0465	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—HIC1—brain cancer	0.00229	0.0383	CbGpPWpGaD
Clofarabine—Azacitidine—DNMT1—brain cancer	0.00173	0.506	CrCbGaD
Clofarabine—Decitabine—DNMT1—brain cancer	0.00169	0.494	CrCbGaD
Clofarabine—POLA1—E2F transcription factor network—HIC1—brain cancer	0.00157	0.0262	CbGpPWpGaD
Clofarabine—RRM2—G1/S-Specific Transcription—CCNE1—brain cancer	0.00156	0.026	CbGpPWpGaD
Clofarabine—RRM2—G1/S-Specific Transcription—PCNA—brain cancer	0.00138	0.023	CbGpPWpGaD
Clofarabine—POLA1—Removal of the Flap Intermediate—PCNA—brain cancer	0.0011	0.0184	CbGpPWpGaD
Clofarabine—POLA1—Leading Strand Synthesis—PCNA—brain cancer	0.0011	0.0184	CbGpPWpGaD
Clofarabine—POLA1—G1/S-Specific Transcription—CCNE1—brain cancer	0.00106	0.0178	CbGpPWpGaD
Clofarabine—POLA1—pituitary gland—brain cancer	0.00102	0.0449	CbGeAlD
Clofarabine—RRM2—gonad—brain cancer	0.000999	0.044	CbGeAlD
Clofarabine—RRM1—telencephalon—brain cancer	0.000995	0.0438	CbGeAlD
Clofarabine—POLA1—Processive synthesis on the lagging strand—PCNA—brain cancer	0.000989	0.0165	CbGpPWpGaD
Clofarabine—RRM2—pituitary gland—brain cancer	0.000975	0.0429	CbGeAlD
Clofarabine—POLA1—G1/S-Specific Transcription—PCNA—brain cancer	0.000942	0.0157	CbGpPWpGaD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.000915	0.0153	CbGpPWpGaD
Clofarabine—RRM1—gonad—brain cancer	0.00083	0.0365	CbGeAlD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.00081	0.0135	CbGpPWpGaD
Clofarabine—RRM1—pituitary gland—brain cancer	0.00081	0.0356	CbGeAlD
Clofarabine—POLA1—Lagging Strand Synthesis—PCNA—brain cancer	0.000796	0.0133	CbGpPWpGaD
Clofarabine—RRM1—medulla oblongata—brain cancer	0.000781	0.0344	CbGeAlD
Clofarabine—DCK—telencephalon—brain cancer	0.000772	0.034	CbGeAlD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000762	0.0127	CbGpPWpGaD
Clofarabine—RRM2—endocrine gland—brain cancer	0.000755	0.0332	CbGeAlD
Clofarabine—RRM2—head—brain cancer	0.000745	0.0328	CbGeAlD
Clofarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—brain cancer	0.00074	0.0123	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000716	0.012	CbGpPWpGaD
Clofarabine—RRM1—midbrain—brain cancer	0.000714	0.0314	CbGeAlD
Clofarabine—RRM1—spinal cord—brain cancer	0.000697	0.0307	CbGeAlD
Clofarabine—POLA1—cerebellum—brain cancer	0.000696	0.0306	CbGeAlD
Clofarabine—RRM2—central nervous system—brain cancer	0.00068	0.03	CbGeAlD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000679	0.0113	CbGpPWpGaD
Clofarabine—DCK—gonad—brain cancer	0.000645	0.0284	CbGeAlD
Clofarabine—DCK—pituitary gland—brain cancer	0.000629	0.0277	CbGeAlD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000627	0.0105	CbGpPWpGaD
Clofarabine—RRM1—endocrine gland—brain cancer	0.000627	0.0276	CbGeAlD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.000626	0.0104	CbGpPWpGaD
Clofarabine—RRM1—head—brain cancer	0.000619	0.0273	CbGeAlD
Clofarabine—POLA1—Extension of Telomeres—PCNA—brain cancer	0.000615	0.0103	CbGpPWpGaD
Clofarabine—DCK—medulla oblongata—brain cancer	0.000607	0.0267	CbGeAlD
Clofarabine—RRM1—E2F transcription factor network—SIRT1—brain cancer	0.000596	0.00995	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.00059	0.00985	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CCNE1—brain cancer	0.000589	0.00982	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000586	0.00979	CbGpPWpGaD
Clofarabine—POLA1—DNA strand elongation—PCNA—brain cancer	0.000568	0.00948	CbGpPWpGaD
Clofarabine—POLA1—brain—brain cancer	0.000565	0.0249	CbGeAlD
Clofarabine—RRM1—central nervous system—brain cancer	0.000565	0.0249	CbGeAlD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000559	0.00933	CbGpPWpGaD
Clofarabine—DCK—midbrain—brain cancer	0.000555	0.0244	CbGeAlD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.000554	0.00925	CbGpPWpGaD
Clofarabine—RRM1—cerebellum—brain cancer	0.000553	0.0243	CbGeAlD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000551	0.0092	CbGpPWpGaD
Clofarabine—DCK—spinal cord—brain cancer	0.000541	0.0238	CbGeAlD
Clofarabine—RRM2—brain—brain cancer	0.00054	0.0238	CbGeAlD
Clofarabine—RRM2—G1/S Transition—SKP2—brain cancer	0.000524	0.00874	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000523	0.00872	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000511	0.00854	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—SIRT1—brain cancer	0.000491	0.00819	CbGpPWpGaD
Clofarabine—ABCG2—Irinotecan Pathway—APC—brain cancer	0.00049	0.00817	CbGpPWpGaD
Clofarabine—DCK—endocrine gland—brain cancer	0.000487	0.0214	CbGeAlD
Clofarabine—RRM2—E2F transcription factor network—CCNE1—brain cancer	0.000485	0.00809	CbGpPWpGaD
Clofarabine—DCK—head—brain cancer	0.000481	0.0212	CbGeAlD
Clofarabine—POLA1—DNA Replication—PCNA—brain cancer	0.000457	0.00763	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000453	0.00756	CbGpPWpGaD
Clofarabine—RRM1—brain—brain cancer	0.000449	0.0198	CbGeAlD
Clofarabine—RRM2—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000441	0.00737	CbGpPWpGaD
Clofarabine—DCK—central nervous system—brain cancer	0.000439	0.0193	CbGeAlD
Clofarabine—ABCG2—telencephalon—brain cancer	0.000431	0.019	CbGeAlD
Clofarabine—DCK—cerebellum—brain cancer	0.000429	0.0189	CbGeAlD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000429	0.00716	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000428	0.00715	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000421	0.00703	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000406	0.00678	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000403	0.00674	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000394	0.00657	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000393	0.00657	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000392	0.00654	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000383	0.00638	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000373	0.00623	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000371	0.0062	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—brain cancer	0.000362	0.00604	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—SKP2—brain cancer	0.000358	0.00598	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000357	0.00595	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—CCNE1—brain cancer	0.000352	0.00587	CbGpPWpGaD
Clofarabine—ABCG2—pituitary gland—brain cancer	0.000351	0.0154	CbGeAlD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000349	0.00582	CbGpPWpGaD
Clofarabine—DCK—brain—brain cancer	0.000349	0.0153	CbGeAlD
Clofarabine—RRM1—E2F transcription factor network—CDKN2A—brain cancer	0.000344	0.00575	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000343	0.00572	CbGpPWpGaD
Clofarabine—ABCG2—medulla oblongata—brain cancer	0.000339	0.0149	CbGeAlD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000338	0.00565	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—SIRT1—brain cancer	0.000336	0.0056	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CCNE1—brain cancer	0.000332	0.00553	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000331	0.00553	CbGpPWpGaD
Clofarabine—POLA1—S Phase—SKP2—brain cancer	0.000325	0.00543	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000323	0.00538	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PPP1R12A—brain cancer	0.000319	0.00532	CbGpPWpGaD
Clofarabine—Tremor—Procarbazine—brain cancer	0.000312	0.00272	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—PCNA—brain cancer	0.000312	0.0052	CbGpPWpGaD
Clofarabine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000312	0.00272	CcSEcCtD
Clofarabine—Dehydration—Temozolomide—brain cancer	0.000311	0.00271	CcSEcCtD
Clofarabine—ABCG2—midbrain—brain cancer	0.000309	0.0136	CbGeAlD
Clofarabine—Anaemia—Procarbazine—brain cancer	0.000307	0.00268	CcSEcCtD
Clofarabine—Dry skin—Temozolomide—brain cancer	0.000306	0.00267	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000302	0.00504	CbGpPWpGaD
Clofarabine—ABCG2—spinal cord—brain cancer	0.000302	0.0133	CbGeAlD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000301	0.00503	CbGpPWpGaD
Clofarabine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000301	0.00262	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000301	0.00262	CcSEcCtD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—brain cancer	0.000298	0.00497	CbGpPWpGaD
Clofarabine—Leukopenia—Procarbazine—brain cancer	0.000298	0.00259	CcSEcCtD
Clofarabine—Haemoglobin—Hydroxyurea—brain cancer	0.000297	0.00259	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000296	0.00495	CbGpPWpGaD
Clofarabine—Haemorrhage—Hydroxyurea—brain cancer	0.000296	0.00258	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000294	0.00257	CcSEcCtD
Clofarabine—Cough—Procarbazine—brain cancer	0.00029	0.00253	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000288	0.00481	CbGpPWpGaD
Clofarabine—Hypertension—Procarbazine—brain cancer	0.000287	0.0025	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—CDKN2A—brain cancer	0.000284	0.00474	CbGpPWpGaD
Clofarabine—Pancytopenia—Carmustine—brain cancer	0.000284	0.00247	CcSEcCtD
Clofarabine—Arthralgia—Procarbazine—brain cancer	0.000283	0.00247	CcSEcCtD
Clofarabine—Myalgia—Procarbazine—brain cancer	0.000283	0.00247	CcSEcCtD
Clofarabine—Anxiety—Procarbazine—brain cancer	0.000282	0.00246	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000282	0.0047	CbGpPWpGaD
Clofarabine—Neutropenia—Carmustine—brain cancer	0.000279	0.00243	CcSEcCtD
Clofarabine—POLA1—Telomere Maintenance—PCNA—brain cancer	0.000279	0.00465	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000276	0.00461	CbGpPWpGaD
Clofarabine—Pancytopenia—Temozolomide—brain cancer	0.000274	0.00239	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000273	0.00455	CbGpPWpGaD
Clofarabine—Vomiting—Lomustine—brain cancer	0.000272	0.00237	CcSEcCtD
Clofarabine—Oedema—Procarbazine—brain cancer	0.000271	0.00237	CcSEcCtD
Clofarabine—Neutropenia—Temozolomide—brain cancer	0.00027	0.00235	CcSEcCtD
Clofarabine—Infection—Procarbazine—brain cancer	0.00027	0.00235	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000269	0.00449	CbGpPWpGaD
Clofarabine—Angiopathy—Hydroxyurea—brain cancer	0.000268	0.00234	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000268	0.00234	CcSEcCtD
Clofarabine—Pneumonia—Carmustine—brain cancer	0.000268	0.00233	CcSEcCtD
Clofarabine—Thrombocytopenia—Procarbazine—brain cancer	0.000266	0.00232	CcSEcCtD
Clofarabine—Chills—Hydroxyurea—brain cancer	0.000265	0.00231	CcSEcCtD
Clofarabine—Tachycardia—Procarbazine—brain cancer	0.000265	0.00231	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000263	0.00438	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Procarbazine—brain cancer	0.000262	0.00229	CcSEcCtD
Clofarabine—Renal failure—Carmustine—brain cancer	0.000262	0.00228	CcSEcCtD
Clofarabine—Alopecia—Hydroxyurea—brain cancer	0.000261	0.00228	CcSEcCtD
Clofarabine—Weight decreased—Temozolomide—brain cancer	0.000261	0.00228	CcSEcCtD
Clofarabine—Neuropathy peripheral—Carmustine—brain cancer	0.000261	0.00228	CcSEcCtD
Clofarabine—Stomatitis—Carmustine—brain cancer	0.00026	0.00226	CcSEcCtD
Clofarabine—Pneumonia—Temozolomide—brain cancer	0.000259	0.00226	CcSEcCtD
Clofarabine—Anorexia—Procarbazine—brain cancer	0.000259	0.00226	CcSEcCtD
Clofarabine—Erythema—Hydroxyurea—brain cancer	0.000257	0.00224	CcSEcCtD
Clofarabine—Infestation—Temozolomide—brain cancer	0.000257	0.00224	CcSEcCtD
Clofarabine—Infestation NOS—Temozolomide—brain cancer	0.000257	0.00224	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000255	0.00426	CbGpPWpGaD
Clofarabine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000255	0.00222	CcSEcCtD
Clofarabine—Nausea—Lomustine—brain cancer	0.000254	0.00221	CcSEcCtD
Clofarabine—Hypotension—Procarbazine—brain cancer	0.000254	0.00221	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000253	0.00423	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000253	0.00422	CbGpPWpGaD
Clofarabine—Neuropathy peripheral—Temozolomide—brain cancer	0.000252	0.0022	CcSEcCtD
Clofarabine—Stomatitis—Temozolomide—brain cancer	0.000251	0.00219	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000247	0.00216	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000244	0.00407	CbGpPWpGaD
Clofarabine—Paraesthesia—Procarbazine—brain cancer	0.000244	0.00212	CcSEcCtD
Clofarabine—Hepatobiliary disease—Temozolomide—brain cancer	0.000243	0.00212	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000242	0.00403	CbGpPWpGaD
Clofarabine—Sinusitis—Temozolomide—brain cancer	0.000241	0.0021	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000241	0.00403	CbGpPWpGaD
Clofarabine—Somnolence—Procarbazine—brain cancer	0.000241	0.0021	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000241	0.0021	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CCNE1—brain cancer	0.000241	0.00402	CbGpPWpGaD
Clofarabine—Haemoglobin—Carmustine—brain cancer	0.00024	0.00209	CcSEcCtD
Clofarabine—ABCG2—cerebellum—brain cancer	0.000239	0.0105	CbGeAlD
Clofarabine—Haemorrhage—Carmustine—brain cancer	0.000239	0.00208	CcSEcCtD
Clofarabine—Anaemia—Hydroxyurea—brain cancer	0.000238	0.00207	CcSEcCtD
Clofarabine—Decreased appetite—Procarbazine—brain cancer	0.000236	0.00206	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—PCNA—brain cancer	0.000236	0.00394	CbGpPWpGaD
Clofarabine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000236	0.00205	CcSEcCtD
Clofarabine—Oedema peripheral—Carmustine—brain cancer	0.000235	0.00205	CcSEcCtD
Clofarabine—Connective tissue disorder—Carmustine—brain cancer	0.000235	0.00205	CcSEcCtD
Clofarabine—Fatigue—Procarbazine—brain cancer	0.000234	0.00204	CcSEcCtD
Clofarabine—RRM1—E2F transcription factor network—MYC—brain cancer	0.000233	0.0039	CbGpPWpGaD
Clofarabine—Haemoglobin—Temozolomide—brain cancer	0.000232	0.00202	CcSEcCtD
Clofarabine—Pain—Procarbazine—brain cancer	0.000232	0.00202	CcSEcCtD
Clofarabine—POLA1—Chromosome Maintenance—PCNA—brain cancer	0.000232	0.00387	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000232	0.00387	CbGpPWpGaD
Clofarabine—Haemorrhage—Temozolomide—brain cancer	0.000231	0.00201	CcSEcCtD
Clofarabine—Leukopenia—Hydroxyurea—brain cancer	0.00023	0.00201	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000229	0.00382	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Temozolomide—brain cancer	0.000228	0.00199	CcSEcCtD
Clofarabine—Oedema peripheral—Temozolomide—brain cancer	0.000228	0.00198	CcSEcCtD
Clofarabine—Connective tissue disorder—Temozolomide—brain cancer	0.000227	0.00198	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000227	0.00379	CbGpPWpGaD
Clofarabine—Urethral disorder—Temozolomide—brain cancer	0.000226	0.00197	CcSEcCtD
Clofarabine—Feeling abnormal—Procarbazine—brain cancer	0.000224	0.00195	CcSEcCtD
Clofarabine—Gastrointestinal pain—Procarbazine—brain cancer	0.000222	0.00193	CcSEcCtD
Clofarabine—Flushing—Carmustine—brain cancer	0.000222	0.00193	CcSEcCtD
Clofarabine—POLA1—DNA Replication—PCNA—brain cancer	0.000221	0.00369	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000221	0.00368	CbGpPWpGaD
Clofarabine—Pancytopenia—Etoposide—brain cancer	0.000219	0.00191	CcSEcCtD
Clofarabine—Erythema multiforme—Temozolomide—brain cancer	0.000218	0.0019	CcSEcCtD
Clofarabine—POLA1—S Phase—CCNE1—brain cancer	0.000218	0.00365	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PPP1R12A—brain cancer	0.000218	0.00364	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000218	0.0019	CcSEcCtD
Clofarabine—Neutropenia—Etoposide—brain cancer	0.000216	0.00188	CcSEcCtD
Clofarabine—Abdominal pain—Procarbazine—brain cancer	0.000215	0.00187	CcSEcCtD
Clofarabine—Body temperature increased—Procarbazine—brain cancer	0.000215	0.00187	CcSEcCtD
Clofarabine—Flushing—Temozolomide—brain cancer	0.000214	0.00187	CcSEcCtD
Clofarabine—Cardiac disorder—Temozolomide—brain cancer	0.000214	0.00187	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—PCNA—brain cancer	0.000213	0.00356	CbGpPWpGaD
Clofarabine—Alopecia—Carmustine—brain cancer	0.000211	0.00184	CcSEcCtD
Clofarabine—Oedema—Hydroxyurea—brain cancer	0.00021	0.00183	CcSEcCtD
Clofarabine—Angiopathy—Temozolomide—brain cancer	0.00021	0.00183	CcSEcCtD
Clofarabine—Mental disorder—Carmustine—brain cancer	0.000209	0.00183	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000209	0.00349	CbGpPWpGaD
Clofarabine—Infection—Hydroxyurea—brain cancer	0.000209	0.00182	CcSEcCtD
Clofarabine—Immune system disorder—Temozolomide—brain cancer	0.000209	0.00182	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000208	0.00348	CbGpPWpGaD
Clofarabine—Mediastinal disorder—Temozolomide—brain cancer	0.000208	0.00181	CcSEcCtD
Clofarabine—Erythema—Carmustine—brain cancer	0.000208	0.00181	CcSEcCtD
Clofarabine—Malnutrition—Carmustine—brain cancer	0.000208	0.00181	CcSEcCtD
Clofarabine—Chills—Temozolomide—brain cancer	0.000207	0.00181	CcSEcCtD
Clofarabine—Pneumonia—Etoposide—brain cancer	0.000207	0.00181	CcSEcCtD
Clofarabine—Nervous system disorder—Hydroxyurea—brain cancer	0.000206	0.0018	CcSEcCtD
Clofarabine—Infestation—Etoposide—brain cancer	0.000206	0.00179	CcSEcCtD
Clofarabine—Infestation NOS—Etoposide—brain cancer	0.000206	0.00179	CcSEcCtD
Clofarabine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000206	0.00179	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000204	0.00178	CcSEcCtD
Clofarabine—Alopecia—Temozolomide—brain cancer	0.000204	0.00178	CcSEcCtD
Clofarabine—Skin disorder—Hydroxyurea—brain cancer	0.000204	0.00178	CcSEcCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000203	0.00339	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000203	0.00338	CbGpPWpGaD
Clofarabine—Renal failure—Etoposide—brain cancer	0.000202	0.00176	CcSEcCtD
Clofarabine—Mental disorder—Temozolomide—brain cancer	0.000202	0.00176	CcSEcCtD
Clofarabine—Neuropathy peripheral—Etoposide—brain cancer	0.000202	0.00176	CcSEcCtD
Clofarabine—Back pain—Carmustine—brain cancer	0.000201	0.00175	CcSEcCtD
Clofarabine—Malnutrition—Temozolomide—brain cancer	0.000201	0.00175	CcSEcCtD
Clofarabine—Erythema—Temozolomide—brain cancer	0.000201	0.00175	CcSEcCtD
Clofarabine—Stomatitis—Etoposide—brain cancer	0.000201	0.00175	CcSEcCtD
Clofarabine—Jaundice—Etoposide—brain cancer	0.000201	0.00175	CcSEcCtD
Clofarabine—Anorexia—Hydroxyurea—brain cancer	0.0002	0.00175	CcSEcCtD
Clofarabine—Hypersensitivity—Procarbazine—brain cancer	0.0002	0.00174	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000197	0.00328	CbGpPWpGaD
Clofarabine—Tremor—Carmustine—brain cancer	0.000195	0.0017	CcSEcCtD
Clofarabine—Asthenia—Procarbazine—brain cancer	0.000195	0.0017	CcSEcCtD
Clofarabine—Hepatobiliary disease—Etoposide—brain cancer	0.000195	0.0017	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000195	0.00325	CbGpPWpGaD
Clofarabine—Back pain—Temozolomide—brain cancer	0.000195	0.0017	CcSEcCtD
Clofarabine—ABCG2—brain—brain cancer	0.000194	0.00856	CbGeAlD
Clofarabine—POLA1—E2F transcription factor network—CDKN2A—brain cancer	0.000194	0.00324	CbGpPWpGaD
Clofarabine—POLA1—S Phase—PCNA—brain cancer	0.000193	0.00323	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000193	0.00322	CbGpPWpGaD
Clofarabine—Anaemia—Carmustine—brain cancer	0.000192	0.00168	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—MYC—brain cancer	0.000192	0.00321	CbGpPWpGaD
Clofarabine—Pruritus—Procarbazine—brain cancer	0.000192	0.00167	CcSEcCtD
Clofarabine—Agitation—Carmustine—brain cancer	0.000191	0.00167	CcSEcCtD
Clofarabine—Tremor—Temozolomide—brain cancer	0.000188	0.00164	CcSEcCtD
Clofarabine—Dyspnoea—Hydroxyurea—brain cancer	0.000187	0.00163	CcSEcCtD
Clofarabine—Somnolence—Hydroxyurea—brain cancer	0.000187	0.00163	CcSEcCtD
Clofarabine—Leukopenia—Carmustine—brain cancer	0.000186	0.00162	CcSEcCtD
Clofarabine—Anaemia—Temozolomide—brain cancer	0.000186	0.00162	CcSEcCtD
Clofarabine—Diarrhoea—Procarbazine—brain cancer	0.000186	0.00162	CcSEcCtD
Clofarabine—Agitation—Temozolomide—brain cancer	0.000185	0.00161	CcSEcCtD
Clofarabine—Decreased appetite—Hydroxyurea—brain cancer	0.000183	0.00159	CcSEcCtD
Clofarabine—Urinary tract disorder—Etoposide—brain cancer	0.000183	0.00159	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000181	0.00158	CcSEcCtD
Clofarabine—Urethral disorder—Etoposide—brain cancer	0.000181	0.00158	CcSEcCtD
Clofarabine—Fatigue—Hydroxyurea—brain cancer	0.000181	0.00158	CcSEcCtD
Clofarabine—Leukopenia—Temozolomide—brain cancer	0.00018	0.00157	CcSEcCtD
Clofarabine—Hypertension—Carmustine—brain cancer	0.00018	0.00157	CcSEcCtD
Clofarabine—Pain—Hydroxyurea—brain cancer	0.00018	0.00157	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—PCNA—brain cancer	0.00018	0.003	CbGpPWpGaD
Clofarabine—Dizziness—Procarbazine—brain cancer	0.000179	0.00156	CcSEcCtD
Clofarabine—Myalgia—Carmustine—brain cancer	0.000177	0.00154	CcSEcCtD
Clofarabine—Anxiety—Carmustine—brain cancer	0.000177	0.00154	CcSEcCtD
Clofarabine—Cough—Temozolomide—brain cancer	0.000175	0.00153	CcSEcCtD
Clofarabine—Erythema multiforme—Etoposide—brain cancer	0.000175	0.00152	CcSEcCtD
Clofarabine—Hypertension—Temozolomide—brain cancer	0.000174	0.00151	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000173	0.0029	CbGpPWpGaD
Clofarabine—Feeling abnormal—Hydroxyurea—brain cancer	0.000173	0.00151	CcSEcCtD
Clofarabine—Vomiting—Procarbazine—brain cancer	0.000173	0.0015	CcSEcCtD
Clofarabine—Flushing—Etoposide—brain cancer	0.000172	0.0015	CcSEcCtD
Clofarabine—Cardiac disorder—Etoposide—brain cancer	0.000172	0.0015	CcSEcCtD
Clofarabine—Arthralgia—Temozolomide—brain cancer	0.000171	0.00149	CcSEcCtD
Clofarabine—Myalgia—Temozolomide—brain cancer	0.000171	0.00149	CcSEcCtD
Clofarabine—Rash—Procarbazine—brain cancer	0.000171	0.00149	CcSEcCtD
Clofarabine—Dermatitis—Procarbazine—brain cancer	0.000171	0.00149	CcSEcCtD
Clofarabine—Anxiety—Temozolomide—brain cancer	0.000171	0.00149	CcSEcCtD
Clofarabine—Headache—Procarbazine—brain cancer	0.00017	0.00148	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00017	0.00148	CcSEcCtD
Clofarabine—Oedema—Carmustine—brain cancer	0.00017	0.00148	CcSEcCtD
Clofarabine—Infection—Carmustine—brain cancer	0.000169	0.00147	CcSEcCtD
Clofarabine—Angiopathy—Etoposide—brain cancer	0.000168	0.00146	CcSEcCtD
Clofarabine—POLA1—S Phase—CDK4—brain cancer	0.000167	0.00279	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000167	0.00279	CbGpPWpGaD
Clofarabine—Immune system disorder—Etoposide—brain cancer	0.000167	0.00146	CcSEcCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000167	0.00278	CbGpPWpGaD
Clofarabine—Mediastinal disorder—Etoposide—brain cancer	0.000167	0.00145	CcSEcCtD
Clofarabine—Thrombocytopenia—Carmustine—brain cancer	0.000166	0.00145	CcSEcCtD
Clofarabine—Body temperature increased—Hydroxyurea—brain cancer	0.000166	0.00145	CcSEcCtD
Clofarabine—Chills—Etoposide—brain cancer	0.000166	0.00145	CcSEcCtD
Clofarabine—Tachycardia—Carmustine—brain cancer	0.000166	0.00144	CcSEcCtD
Clofarabine—Oedema—Temozolomide—brain cancer	0.000164	0.00143	CcSEcCtD
Clofarabine—Alopecia—Etoposide—brain cancer	0.000163	0.00142	CcSEcCtD
Clofarabine—Infection—Temozolomide—brain cancer	0.000163	0.00142	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—SKP2—brain cancer	0.000162	0.0027	CbGpPWpGaD
Clofarabine—Anorexia—Carmustine—brain cancer	0.000162	0.00141	CcSEcCtD
Clofarabine—Nausea—Procarbazine—brain cancer	0.000161	0.00141	CcSEcCtD
Clofarabine—Nervous system disorder—Temozolomide—brain cancer	0.000161	0.0014	CcSEcCtD
Clofarabine—Thrombocytopenia—Temozolomide—brain cancer	0.000161	0.0014	CcSEcCtD
Clofarabine—Skin disorder—Temozolomide—brain cancer	0.000159	0.00139	CcSEcCtD
Clofarabine—Hypotension—Carmustine—brain cancer	0.000159	0.00138	CcSEcCtD
Clofarabine—Hyperhidrosis—Temozolomide—brain cancer	0.000159	0.00138	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000159	0.00265	CbGpPWpGaD
Clofarabine—Anorexia—Temozolomide—brain cancer	0.000156	0.00136	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000156	0.00261	CbGpPWpGaD
Clofarabine—Back pain—Etoposide—brain cancer	0.000156	0.00136	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000156	0.0026	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000155	0.00259	CbGpPWpGaD
Clofarabine—Hypersensitivity—Hydroxyurea—brain cancer	0.000155	0.00135	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000155	0.00135	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000154	0.00256	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000153	0.00255	CbGpPWpGaD
Clofarabine—Paraesthesia—Carmustine—brain cancer	0.000152	0.00133	CcSEcCtD
Clofarabine—Dyspnoea—Carmustine—brain cancer	0.000151	0.00132	CcSEcCtD
Clofarabine—Somnolence—Carmustine—brain cancer	0.000151	0.00132	CcSEcCtD
Clofarabine—Asthenia—Hydroxyurea—brain cancer	0.000151	0.00131	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00015	0.0013	CcSEcCtD
Clofarabine—Anaemia—Etoposide—brain cancer	0.000149	0.0013	CcSEcCtD
Clofarabine—Decreased appetite—Carmustine—brain cancer	0.000148	0.00129	CcSEcCtD
Clofarabine—Paraesthesia—Temozolomide—brain cancer	0.000147	0.00128	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Carmustine—brain cancer	0.000147	0.00128	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000147	0.00245	CbGpPWpGaD
Clofarabine—Dyspnoea—Temozolomide—brain cancer	0.000146	0.00128	CcSEcCtD
Clofarabine—Somnolence—Temozolomide—brain cancer	0.000146	0.00127	CcSEcCtD
Clofarabine—Pain—Carmustine—brain cancer	0.000145	0.00127	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—SKP2—brain cancer	0.000145	0.00242	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK6—brain cancer	0.000144	0.00241	CbGpPWpGaD
Clofarabine—Leukopenia—Etoposide—brain cancer	0.000144	0.00126	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000144	0.0024	CbGpPWpGaD
Clofarabine—Diarrhoea—Hydroxyurea—brain cancer	0.000144	0.00125	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000143	0.00238	CbGpPWpGaD
Clofarabine—Decreased appetite—Temozolomide—brain cancer	0.000143	0.00124	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000142	0.00238	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000142	0.00123	CcSEcCtD
Clofarabine—Fatigue—Temozolomide—brain cancer	0.000141	0.00123	CcSEcCtD
Clofarabine—Cough—Etoposide—brain cancer	0.00014	0.00122	CcSEcCtD
Clofarabine—Pain—Temozolomide—brain cancer	0.00014	0.00122	CcSEcCtD
Clofarabine—Feeling abnormal—Carmustine—brain cancer	0.00014	0.00122	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—MYC—brain cancer	0.000139	0.00233	CbGpPWpGaD
Clofarabine—Hypertension—Etoposide—brain cancer	0.000139	0.00121	CcSEcCtD
Clofarabine—Dizziness—Hydroxyurea—brain cancer	0.000139	0.00121	CcSEcCtD
Clofarabine—Gastrointestinal pain—Carmustine—brain cancer	0.000139	0.00121	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP2C9—brain cancer	0.000138	0.0023	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000137	0.00229	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000136	0.00119	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000136	0.00227	CbGpPWpGaD
Clofarabine—Feeling abnormal—Temozolomide—brain cancer	0.000135	0.00118	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000135	0.00225	CbGpPWpGaD
Clofarabine—Body temperature increased—Carmustine—brain cancer	0.000134	0.00117	CcSEcCtD
Clofarabine—Abdominal pain—Carmustine—brain cancer	0.000134	0.00117	CcSEcCtD
Clofarabine—Gastrointestinal pain—Temozolomide—brain cancer	0.000134	0.00117	CcSEcCtD
Clofarabine—Vomiting—Hydroxyurea—brain cancer	0.000134	0.00116	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000134	0.00223	CbGpPWpGaD
Clofarabine—Rash—Hydroxyurea—brain cancer	0.000132	0.00115	CcSEcCtD
Clofarabine—Dermatitis—Hydroxyurea—brain cancer	0.000132	0.00115	CcSEcCtD
Clofarabine—Headache—Hydroxyurea—brain cancer	0.000132	0.00115	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—MYC—brain cancer	0.000131	0.00219	CbGpPWpGaD
Clofarabine—Infection—Etoposide—brain cancer	0.00013	0.00114	CcSEcCtD
Clofarabine—Body temperature increased—Temozolomide—brain cancer	0.00013	0.00113	CcSEcCtD
Clofarabine—Abdominal pain—Temozolomide—brain cancer	0.00013	0.00113	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDK6—brain cancer	0.000129	0.00215	CbGpPWpGaD
Clofarabine—Thrombocytopenia—Etoposide—brain cancer	0.000129	0.00112	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000128	0.00214	CbGpPWpGaD
Clofarabine—Tachycardia—Etoposide—brain cancer	0.000128	0.00112	CcSEcCtD
Clofarabine—Skin disorder—Etoposide—brain cancer	0.000128	0.00111	CcSEcCtD
Clofarabine—Hyperhidrosis—Etoposide—brain cancer	0.000127	0.00111	CcSEcCtD
Clofarabine—Anorexia—Etoposide—brain cancer	0.000125	0.00109	CcSEcCtD
Clofarabine—Hypersensitivity—Carmustine—brain cancer	0.000125	0.00109	CcSEcCtD
Clofarabine—Nausea—Hydroxyurea—brain cancer	0.000125	0.00109	CcSEcCtD
Clofarabine—Hypotension—Etoposide—brain cancer	0.000123	0.00107	CcSEcCtD
Clofarabine—Asthenia—Carmustine—brain cancer	0.000122	0.00106	CcSEcCtD
Clofarabine—Hypersensitivity—Temozolomide—brain cancer	0.000121	0.00105	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000119	0.00198	CbGpPWpGaD
Clofarabine—Paraesthesia—Etoposide—brain cancer	0.000118	0.00103	CcSEcCtD
Clofarabine—Asthenia—Temozolomide—brain cancer	0.000118	0.00103	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000118	0.00196	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—brain cancer	0.000118	0.00196	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000118	0.00196	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—BSG—brain cancer	0.000117	0.00196	CbGpPWpGaD
Clofarabine—Dyspnoea—Etoposide—brain cancer	0.000117	0.00102	CcSEcCtD
Clofarabine—Somnolence—Etoposide—brain cancer	0.000117	0.00102	CcSEcCtD
Clofarabine—Diarrhoea—Carmustine—brain cancer	0.000116	0.00101	CcSEcCtD
Clofarabine—Pruritus—Temozolomide—brain cancer	0.000116	0.00101	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000114	0.00191	CbGpPWpGaD
Clofarabine—Decreased appetite—Etoposide—brain cancer	0.000114	0.000995	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP2C9—brain cancer	0.000114	0.00189	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Etoposide—brain cancer	0.000113	0.000988	CcSEcCtD
Clofarabine—Fatigue—Etoposide—brain cancer	0.000113	0.000987	CcSEcCtD
Clofarabine—Dizziness—Carmustine—brain cancer	0.000112	0.000979	CcSEcCtD
Clofarabine—Pain—Etoposide—brain cancer	0.000112	0.000979	CcSEcCtD
Clofarabine—Diarrhoea—Temozolomide—brain cancer	0.000112	0.000979	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	0.000111	0.00186	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—SKP2—brain cancer	0.000111	0.00185	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000111	0.00185	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000109	0.00183	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000109	0.00181	CbGpPWpGaD
Clofarabine—Dizziness—Temozolomide—brain cancer	0.000109	0.000946	CcSEcCtD
Clofarabine—Feeling abnormal—Etoposide—brain cancer	0.000108	0.000943	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000108	0.00181	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCND1—brain cancer	0.000108	0.0018	CbGpPWpGaD
Clofarabine—Vomiting—Carmustine—brain cancer	0.000108	0.000941	CcSEcCtD
Clofarabine—Gastrointestinal pain—Etoposide—brain cancer	0.000107	0.000936	CcSEcCtD
Clofarabine—Rash—Carmustine—brain cancer	0.000107	0.000933	CcSEcCtD
Clofarabine—Dermatitis—Carmustine—brain cancer	0.000107	0.000932	CcSEcCtD
Clofarabine—Headache—Carmustine—brain cancer	0.000106	0.000927	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP2C9—brain cancer	0.000106	0.00177	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000106	0.00177	CbGpPWpGaD
Clofarabine—Vomiting—Temozolomide—brain cancer	0.000104	0.00091	CcSEcCtD
Clofarabine—Abdominal pain—Etoposide—brain cancer	0.000104	0.000905	CcSEcCtD
Clofarabine—Body temperature increased—Etoposide—brain cancer	0.000104	0.000905	CcSEcCtD
Clofarabine—Rash—Temozolomide—brain cancer	0.000103	0.000902	CcSEcCtD
Clofarabine—Dermatitis—Temozolomide—brain cancer	0.000103	0.000901	CcSEcCtD
Clofarabine—Headache—Temozolomide—brain cancer	0.000103	0.000896	CcSEcCtD
Clofarabine—Nausea—Carmustine—brain cancer	0.000101	0.000879	CcSEcCtD
Clofarabine—RRM1—Metabolism—IDH1—brain cancer	0.000101	0.00168	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BRCA2—brain cancer	0.0001	0.00168	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—brain cancer	0.0001	0.00167	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—SKP2—brain cancer	9.9e-05	0.00165	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	9.89e-05	0.00165	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK6—brain cancer	9.87e-05	0.00165	CbGpPWpGaD
Clofarabine—Nausea—Temozolomide—brain cancer	9.75e-05	0.00085	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCNE1—brain cancer	9.72e-05	0.00162	CbGpPWpGaD
Clofarabine—Hypersensitivity—Etoposide—brain cancer	9.68e-05	0.000843	CcSEcCtD
Clofarabine—RRM2—Metabolism—BSG—brain cancer	9.65e-05	0.00161	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PCNA—brain cancer	9.63e-05	0.00161	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—brain cancer	9.54e-05	0.00159	CbGpPWpGaD
Clofarabine—Asthenia—Etoposide—brain cancer	9.42e-05	0.000821	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	9.38e-05	0.00157	CbGpPWpGaD
Clofarabine—Pruritus—Etoposide—brain cancer	9.29e-05	0.00081	CcSEcCtD
Clofarabine—DCK—Metabolism—BSG—brain cancer	9.02e-05	0.00151	CbGpPWpGaD
Clofarabine—Diarrhoea—Etoposide—brain cancer	8.99e-05	0.000783	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.88e-05	0.00148	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK6—brain cancer	8.83e-05	0.00147	CbGpPWpGaD
Clofarabine—Dizziness—Etoposide—brain cancer	8.68e-05	0.000757	CcSEcCtD
Clofarabine—POLA1—S Phase—MYC—brain cancer	8.66e-05	0.00145	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PCNA—brain cancer	8.61e-05	0.00144	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	8.6e-05	0.00143	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	8.47e-05	0.00141	CbGpPWpGaD
Clofarabine—Vomiting—Etoposide—brain cancer	8.35e-05	0.000728	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK4—brain cancer	8.32e-05	0.00139	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—IDH1—brain cancer	8.3e-05	0.00139	CbGpPWpGaD
Clofarabine—Rash—Etoposide—brain cancer	8.28e-05	0.000722	CcSEcCtD
Clofarabine—Dermatitis—Etoposide—brain cancer	8.27e-05	0.000721	CcSEcCtD
Clofarabine—Headache—Etoposide—brain cancer	8.23e-05	0.000717	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—brain cancer	8.04e-05	0.00134	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ENO2—brain cancer	7.97e-05	0.00133	CbGpPWpGaD
Clofarabine—Nausea—Etoposide—brain cancer	7.8e-05	0.00068	CcSEcCtD
Clofarabine—DCK—Metabolism—IDH1—brain cancer	7.76e-05	0.00129	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.59e-05	0.00127	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	7.52e-05	0.00126	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDK4—brain cancer	7.44e-05	0.00124	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCNE1—brain cancer	7.43e-05	0.00124	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—BRCA2—brain cancer	6.86e-05	0.00115	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCNE1—brain cancer	6.65e-05	0.00111	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.62e-05	0.00111	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PCNA—brain cancer	6.59e-05	0.0011	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ENO2—brain cancer	6.56e-05	0.0011	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—brain cancer	6.36e-05	0.00106	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ENO2—brain cancer	6.13e-05	0.00102	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.09e-05	0.00102	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.96e-05	0.000995	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PCNA—brain cancer	5.89e-05	0.000983	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK4—brain cancer	5.69e-05	0.00095	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2A—brain cancer	5.69e-05	0.00095	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—brain cancer	5.38e-05	0.000897	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK4—brain cancer	5.09e-05	0.00085	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	5.05e-05	0.000843	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5e-05	0.000835	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND1—brain cancer	4.81e-05	0.000802	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—brain cancer	4.35e-05	0.000726	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—brain cancer	4.31e-05	0.00072	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2C9—brain cancer	4.25e-05	0.000709	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—brain cancer	3.89e-05	0.000649	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—brain cancer	3.86e-05	0.000643	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—brain cancer	3.68e-05	0.000614	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CG—brain cancer	3.66e-05	0.00061	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BSG—brain cancer	3.61e-05	0.000603	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—brain cancer	3.29e-05	0.000549	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—brain cancer	3.17e-05	0.000528	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—IDH1—brain cancer	3.1e-05	0.000518	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—brain cancer	3.01e-05	0.000502	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—brain cancer	2.95e-05	0.000492	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—brain cancer	2.81e-05	0.00047	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—brain cancer	2.64e-05	0.00044	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ENO2—brain cancer	2.45e-05	0.00041	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—brain cancer	2.17e-05	0.000361	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—brain cancer	1.13e-05	0.000188	CbGpPWpGaD
